Achmea Investment Management B.V. Has $7.24 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Achmea Investment Management B.V. increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.0% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 22,521 shares of the company’s stock after buying an additional 868 shares during the period. Achmea Investment Management B.V.’s holdings in HCA Healthcare were worth $7,235,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Atlantic Edge Private Wealth Management LLC bought a new position in HCA Healthcare in the 4th quarter worth approximately $27,000. Bangor Savings Bank lifted its stake in shares of HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares during the period. MFA Wealth Advisors LLC acquired a new stake in HCA Healthcare in the second quarter worth about $27,000. Unique Wealth Strategies LLC acquired a new position in HCA Healthcare during the 2nd quarter valued at about $28,000. Finally, GPS Wealth Strategies Group LLC grew its position in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares during the period. 62.73% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock valued at $6,407,273 over the last 90 days. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Trading Up 0.8 %

Shares of NYSE:HCA opened at $391.57 on Friday. The stock has a market capitalization of $102.56 billion, a PE ratio of 19.52, a price-to-earnings-growth ratio of 1.45 and a beta of 1.67. The company’s 50-day moving average price is $360.70 and its two-hundred day moving average price is $337.60. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $403.05.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same quarter in the previous year, the firm earned $4.29 EPS. The business’s quarterly revenue was up 10.3% on a year-over-year basis. On average, equities analysts forecast that HCA Healthcare, Inc. will post 22.48 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a $0.66 dividend. The ex-dividend date is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.67%. HCA Healthcare’s payout ratio is 13.16%.

Analyst Upgrades and Downgrades

A number of analysts have commented on HCA shares. Robert W. Baird started coverage on shares of HCA Healthcare in a report on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price for the company. Oppenheimer raised their target price on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. UBS Group upped their price target on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Baird R W raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Leerink Partners boosted their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $359.89.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.